Study Evaluating Patients With Cystinuria

NCT04137978 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Unspecified business decision/strategic reason

Conditions

Cystinuria

Interventions

DRUG: ADV7103
DRUG: Standard of Care

Sponsor

Advicenne Pharma